Houston biopharma company CoRegen said it has received US Food and Drug Administration clearance to begin a Phase I/II trial of CRG-150, an adoptive cell therapy targeting steroid receptor coactivator ...
Medicare has expanded access to GLP-1 weight-loss medications. These drugs may also help treat addiction. Primary care ...
Peptide may not yet be the 2026 Oxford Word of the Year, but it must surely be in the running. From your friendly ...
Years ago, LSD was seen as the evil stepchild of drugs. Today, research indicates LSD may treat anxiety and depression, and ...
The strain of the virus that's responsible for the current outbreak has no specific treatments or preventive measures. Three ...
Phase 1/2a Clinical Trial to Evaluate Safety and Preliminary Efficacy of CRG-150 in Metastatic Triple-Negative Breast Cancer, HR+ HER2− Breast Cancer, and Prostate Cancer at Leading Academic Medical C ...
The healthcare sector extended its recent recovery despite broader market weakness, with several key milestones looming across the sector.
Forbes contributors publish independent expert analyses and insights. Founder & Advisor on Emerging Tech. Covering VC. This voice experience is generated by AI. Learn more. This voice experience is ...
On April 26, 58-year-old ultramarathoner, podcaster, and bowhunting influencer Cameron “Cam” Hanes ran 2:39:11 in the Eugene Marathon, winning the masters division. The runner-up, who Hanes outkicked ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Jeff Bezos, founder of Amazon, just predicted in a CNBC interview that rather than gut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results